Fibrodysplasia Ossificans Progressiva Clinical Trial
Official title:
Phase 3 Randomized, Placebo-Controlled Study to Assess Safety, Tolerability, and Efficacy of Garetosmab in Patients With Fibrodysplasia Ossificans Progressiva
This study is researching an experimental drug called garetosmab. The study is focused on adult patients with fibrodysplasia ossificans progressiva (FOP). The aim of the study is to see how safe and effective the study drug is in patients with FOP. The study is looking at several other research questions, including: - What side effects may happen from receiving the study drug - How much study drug is in your blood at different times - Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02279095 -
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
|
Phase 2 | |
Completed |
NCT03312634 -
An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.
|
Phase 3 | |
Completed |
NCT02979769 -
An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in People With Fibrodysplasia Ossificans Progressiva (FOP) in France
|
Phase 2 | |
Completed |
NCT02066324 -
Urine Sample Collection From FOP Patients
|
N/A | |
Completed |
NCT02190747 -
An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
|
Phase 2 | |
Completed |
NCT04829773 -
Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT04665323 -
An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.
|
||
Completed |
NCT03188666 -
A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva
|
Phase 2 | |
Terminated |
NCT02521792 -
In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
|
Phase 2 | |
Completed |
NCT02322255 -
A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
|
||
Recruiting |
NCT05039515 -
A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).
|
Phase 2 | |
Recruiting |
NCT04307953 -
Saracatinib Trial TO Prevent FOP
|
Phase 2 | |
Not yet recruiting |
NCT06089616 -
A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
|
||
Completed |
NCT04818398 -
Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects
|
Phase 1 |